Multi-Omics Analysis of Western-style Diet Increased Susceptibility to Experimental Colitis in Mice

References

• Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474(7351):307–317. doi:10.1038/nature10209
   PubMed Web of Science ®Google Scholar
• Levine A, Boneh RS, Wine E. Evolving role of diet in the pathogenesis and treatment of inflammatory bowel diseases. Gut. 2018;67(9):1726–1738. doi:10.1136/gutjnl-2017-315866
   PubMed Web of Science ®Google Scholar
• Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140(6):1785–1794. doi:10.1053/j.gastro.2011.01.055
   PubMed Web of Science ®Google Scholar
• Wilson J, Hair C, Knight R, et al. High incidence of inflammatory bowel disease in Australia: a prospective population-based Australian incidence study. Inflamm Bowel Dis. 2010;16(9):1550–1556. doi:10.1002/ibd.21209
   PubMed Web of Science ®Google Scholar
• Rizzello F, Spisni E, Giovanardi E, et al. Implications of the Westernized diet in the onset and progression of IBD. Nutrients. 2019;11(5):1033. doi:10.3390/nu11051033
   PubMed Web of Science ®Google Scholar
• Amre DK, D’Souza S, Morgan K, et al. Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn’s disease in children. Am J Gastroenterol. 2007;102(9):2016–2025. doi:10.1111/j.1572-0241.2007.01411.x
   PubMed Web of Science ®Google Scholar
• Li T, Qiu Y, Yang HS, et al. Systematic review and meta-analysis: association of a pre-illness Western dietary pattern with the risk of developing inflammatory bowel disease. J Dig Dis. 2020;21(7):362–371. doi:10.1111/1751-2980.12910
   PubMed Web of Science ®Google Scholar
• Mayr L, Grabherr F, Schwrzler J, et al. Dietary lipids fuel GPX4-restricted enteritis resembling Crohn’s disease. Nat Commun. 2020;11(1):1775. doi:10.1038/s41467-020-15646-6
   PubMed Web of Science ®Google Scholar
• Andersen V, Hansen AK, Heitmann BL. Potential impact of diet on treatment effect from anti-TNF drugs in inflammatory bowel disease. Nutrients. 2017;9(3):286. doi:10.3390/nu9030286
   PubMed Web of Science ®Google Scholar
• Lloyd-Price J, Arze C, Ananthakrishnan AN, et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature. 2019;569(7758):655–662. doi:10.1038/s41586-019-1237-9
   PubMed Web of Science ®Google Scholar
• Girgenti MJ, Duman RS. Transcriptome alterations in posttraumatic stress disorder. Biol Psychiatry. 2018;83(10):840–848. doi:10.1016/j.biopsych.2017.09.023
   PubMed Web of Science ®Google Scholar
• Patti GJ, Yanes O, Siuzdak G. Innovation: Metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol. 2012;13(4):263–269. doi:10.1038/nrm3314
   PubMed Web of Science ®Google Scholar
• Perse M, Cerar A. Dextran sodium sulphate colitis mouse model: traps and tricks. J Biomed Biotechnol. 2012;2012:718617. doi:10.1155/2012/718617
   PubMedGoogle Scholar
• Strober W, Fuss IJ, Blumberg RS. The immunology of mucosal models of inflammation. Annu Rev Immunol. 2002;20:495–549. doi:10.1146/annurev.immunol.20.100301.064816
   PubMed Web of Science ®Google Scholar
• Wirtz S, Popp V, Kindermann M, et al. Chemically induced mouse models of acute and chronic intestinal inflammation. Nat Protoc. 2017;12(7):1295–1309. doi:10.1038/nprot.2017.044
   PubMed Web of Science ®Google Scholar
• Soares PMG, Mota JM, Gomes AS, et al. Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution. Cancer Chemoth Pharm. 2008;63(1):91–98. doi:10.1007/s00280-008-0715-9
   PubMed Web of Science ®Google Scholar
• Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313–1321. doi:10.1002/hep.20701
   PubMed Web of Science ®Google Scholar
• Matsumoto M, Hada N, Sakamaki Y, et al. An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis. Int J Exp Pathol. 2013;94(2):93–103. doi:10.1111/iep.12008
   PubMed Web of Science ®Google Scholar
• Zou W, She J, Tolstikov VV. A comprehensive workflow of mass spectrometry-based untargeted metabolomics in cancer metabolic biomarker discovery using human plasma and urine. Metabolites. 2013;3(3):787–819. doi:10.3390/metabo3030787
   PubMedGoogle Scholar
• Xu XY, Yuan XX, Li NJ, Dewey WL, Li PL, Zhang F. Lysosomal cholesterol accumulation in macrophages leading to coronary atherosclerosis in CD38(-/-) mice. J Cell Mol Med. 2016;20(6):1001–1013. doi:10.1111/jcmm.12788
   PubMed Web of Science ®Google Scholar
• Wu HZ, Ghosh S, Perrard XD, et al. T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation. 2007;115(8):1029–1038. doi:10.1161/CIRCULATIONAHA.106.638379
   PubMed Web of Science ®Google Scholar
• Kassel KM, Sullivan BP, Cui W, Copple BL, Luyendyk JP. Therapeutic administration of the direct thrombin inhibitor argatroban reduces hepatic inflammation in mice with established fatty liver disease. Am J Pathol. 2012;181(4):1287–1295. doi:10.1016/j.ajpath.2012.06.011
   PubMed Web of Science ®Google Scholar
• Borren NZ, Conway G, Garber JJ, et al. Differences in clinical course, genetics, and the microbiome between familial and sporadic inflammatory bowel diseases. J Crohns Colitis. 2018;12(5):525–531. doi:10.1093/ecco-jcc/jjx154
   PubMed Web of Science ®Google Scholar
• Hwang SW, Kwak MS, Kim WS, et al. Influence of a positive family history on the clinical course of inflammatory bowel disease. J Crohns Colitis. 2016;10(9):1024–1032. doi:10.1093/ecco-jcc/jjw063
   PubMed Web of Science ®Google Scholar
• Du P, Sun C, Ashburn J, et al. Risk factors for Crohn’s disease of the neo-small intestine in ulcerative colitis patients with total proctocolectomy and primary or secondary ileostomies. J Crohns Colitis. 2015;9(2):170–176. doi:10.1093/ecco-jcc/jju014
   PubMed Web of Science ®Google Scholar
• De Greef E, Mahachie John JM, Hoffman I, et al. Profile of pediatric Crohn’s disease in Belgium. J Crohns Colitis. 2013;7(11):e588–e598. doi:10.1016/j.crohns.2013.04.016
   PubMedGoogle Scholar
• Arike L, Holmen-Larsson J, Hansson GC. Intestinal Muc2 mucin O-glycosylation is affected by microbiota and regulated by differential expression of glycosyltranferases. Glycobiol. 2017;27(4):318–328. doi:10.1093/glycob/cww134
   PubMed Web of Science ®Google Scholar
• Kudelka MR, Hinrichs BH, Darby T, et al. Cosmc is an X-linked inflammatory bowel disease risk gene that spatially regulates gut microbiota and contributes to sex-specific risk. Proc Natl Acad Sci U S A. 2016;113(51):14787–14792. doi:10.1073/pnas.1612158114
   PubMed Web of Science ®Google Scholar
• Kudelka MR, Stowell SR, Cummings RD, Neish AS. Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD. Nat Rev Gastroenterol Hepatol. 2020;17(10):597–617. doi:10.1038/s41575-020-0331-7
   PubMed Web of Science ®Google Scholar
• Townsend EA, Miller VM, Prakash YS. Sex differences and sex steroids in lung health and disease. Endocr Rev. 2012;33(1):1–47. doi:10.1210/er.2010-0031
   PubMed Web of Science ®Google Scholar
• Garcia-Gomez E, Gonzalez-Pedrajo B, Camacho-Arroyo I. Role of sex steroid hormones in bacterial-host interactions. Biomed Res Int. 2013;2013:928290. doi:10.1155/2013/928290
   PubMed Web of Science ®Google Scholar